Novo Holdings' investment ambitions boosted by Ozempic and Wegovy income – Financial Times
Business News
- Novo Holdings’ investment ambitions boosted by Ozempic and Wegovy income Financial Times
- Novo Holder Boosts Investments With $7 Billion Goal, FT Reports Bloomberg
- Ozempic Maker’s Parent Company To Invest $7B Annually By 2030: ‘We Have More Money Than Ever To Invest’ – Benzinga
- Novo Nordisk’s controlling shareholder plans to invest up to $7 billion a year by 2030 – FT Yahoo News
- Novo Nordisk’s controlling shareholder plans to allocate up to $7 bln a year by 2030 – FT XM
Source: Business News